C1ORF172 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.079800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.592800E-01
Normal-vs-Stage2
2.146000E-01
Normal-vs-Stage3
7.399600E-01
Normal-vs-Stage4
1.659380E-01
Stage1-vs-Stage2
7.716200E-01
Stage1-vs-Stage3
3.789200E-01
Stage1-vs-Stage4
1.800770E-01
Stage2-vs-Stage3
3.978400E-01
Stage2-vs-Stage4
2.487000E-01
Stage3-vs-Stage4
1.485030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.185800E-01
Normal-vs-AfricanAmerican
2.766600E-01
Normal-vs-Asian
2.507600E-01
Caucasian-vs-AfricanAmerican
5.998400E-01
Caucasian-vs-Asian
6.082800E-01
AfricanAmerican-vs-Asian
9.187600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.725610E-01
Normal-vs-Female
2.678800E-01
Male-vs-Female
9.317800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.164800E-01
Normal-vs-Age(41-60Yrs)
1.792410E-01
Normal-vs-Age(61-80Yrs)
2.500200E-01
Normal-vs-Age(81-100Yrs)
2.705800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.277200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.953400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.749400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.204400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.778200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.394600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.795400E-01
Normal-vs-Daily Drinker
1.413240E-01
Normal-vs-Weekly Drinker
5.787000E-01
Normal-vs-Occasional Drinker
7.820500E-02
Normal-vs-Social Drinker
3.127400E-01
Non Drinker-vs-Daily Drinker
7.597600E-02
Non Drinker-vs-Weekly Drinker
4.577800E-01
Non Drinker-vs-Occasional Drinker
4.935200E-03
Non Drinker-vs-Social Drinker
9.217600E-01
Daily Drinker-vs-Weekly Drinker
3.611800E-02
Daily Drinker-vs-Occasional Drinker
2.467000E-01
Daily Drinker-vs-Social Drinker
1.437440E-01
Weekly Drinker-vs-Occasional Drinker
5.020400E-03
Weekly Drinker-vs-Social Drinker
3.982000E-01
Occasional Drinker-vs-Social Drinker
1.933980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.671900E-02
Normal-vs-Grade 2
1.183860E-02
Normal-vs-Grade 3
6.447800E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.859600E-01
Grade 1-vs-Grade 3
6.816200E-01
Grade 1-vs-Grade 4
2.671900E-02
Grade 2-vs-Grade 3
5.513200E-01
Grade 2-vs-Grade 4
1.183860E-02
Grade 3-vs-Grade 4
6.447800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.752000E-01
Normal-vs-NonDiabetic
1.426850E-01
Diabetic-vs-NonDiabetic
5.156100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.564200E-01
Normal-vs-NoPancreatitis
2.356000E-01
Pancreatitis-vs-NoPancreatitis
4.980000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.613600E-01
Normal-vs-N1
2.495400E-01
N0-vs-N1
5.405800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.293900E-02
Normal-vs-TP53-NonMutant
2.005000E-01
TP53-Mutant-vs-TP53-NonMutant
1.659100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
